ArticleTrials2022

Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial.

Yujin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.